Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

774
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
774
T Cell Types and Functions01:24

T Cell Types and Functions

1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

951
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
951

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Local and circulating cytotoxic CD4⁺ T cells are early markers of disease activity in pediatric Crohn's disease.

medRxiv : the preprint server for health sciences·2026
Same author

SOT201: <i>cis</i>-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumors.

Expert opinion on investigational drugs·2026
Same author

NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinoma.

Nature communications·2026
Same author

Aluminum Genotoxicity in Plants, Mammals, and Unicellular Eukaryotes: The Underlying Mechanisms.

International journal of molecular sciences·2026
Same author

CMTM6 suppresses cell-surface expression of death receptor FAS in mice but not in humans.

EMBO reports·2026
Same author

Interindividual Variability in Duration of Action of Rocuronium in Paediatric Patients (DurAct): A Prospective Observational Study.

Children (Basel, Switzerland)·2026

相关实验视频

Updated: Jul 13, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.0K

基于IL-2的CD8+T细胞表型:对免疫治疗的影响

Veronika Niederlova1, Oksana Tsyklauri1, Marek Kovar2

  • 1Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.

Trends in immunology
|October 12, 2023
PubMed
概括

干白素-2 (IL-2) 癌症疗法通过激活CD8+ T细胞显示出有前途. 新的仿真蛋白可能会克服局限性,这表明调节性T细胞 (Tregs) 在抑制免疫力中的作用被高估了.

关键词:
在IL-2中,IL-2被认为是IL-2.在PD-1中使用PD-1.癌症 癌症 癌症 癌症 癌症细胞毒性T细胞的发生.免疫疗法 免疫疗法监管性T细胞监管性T细胞

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

相关实验视频

Last Updated: Jul 13, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.0K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 介质素-2 (IL-2) 已知在癌症中具有治疗潜力,但临床应用有限.
  • 结合抗PD-1抗体和IL-2变体的化学蛋白质在小鼠中诱导强大的抗瘤免疫力.
  • 这种免疫力由独特的 CD8+ T 细胞进行介导,类似于调控性 T 细胞 (Treg) 枯竭产生的免疫力.

研究的目的:

  • 阐明基于IL-2的生物药物增强抗瘤反应的细胞机制.
  • 在IL-2免疫治疗的背景下,提出对调节性T细胞 (Tregs) 的作用的修订理解.

主要方法:

  • 关于IL-2变体和嵌合蛋白蛋白疗法的最新发现的审查和解释.
  • 对T细胞子集的分析,特别是CD8+T细胞和Tregs,对免疫治疗的反应.

主要成果:

  • 基于IL-2的生物制剂可以通过特定的CD8+T细胞激活诱导强大的抗瘤和抗病毒免疫力.
  • 由Tregs进行的IL-2隔离是Treg介导的CD8+T细胞抑制的一个拟议机制.
  • 在接受IL-2治疗的患者中,Tregs对免疫抑制的贡献可能不如以前想象的那么重要.

结论:

  • 基于IL-2的生物制剂提供了一种有希望的策略,可以在细胞水平上增强抗瘤免疫力.
  • 重新评估Tregs在IL-2免疫治疗中的作用是有必要的,可能会揭示新的治疗途径.